DM
Therapeutic Areas
Initiator Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pudafensine | Vulvodynia (Neuropathic Pain) | Phase IIa |
| IP2018 | Erectile Dysfunction (Psychogenic Origin) | Phase I/II |
Leadership Team at Initiator Pharma
DC
Dr. Claus Olesen
Co-founder
DD
Dr. Dan Peters
Co-founder, Chief Scientific Officer (CSO)
PU
Professor Ulf Simonsen
Co-founder
DI
Dr. Irwin Goldstein
Scientific and Clinical Advisory Board Member
MS
Mrs. Sue Goldstein
Scientific and Clinical Advisory Board Member